Neftaly: Iron Deficiency Anemia Screening

???? Detect Early. Treat Effectively. Improve Lives.

Iron Deficiency Anemia (IDA) is the most common nutritional deficiency worldwide, affecting children, women of reproductive age, and other vulnerable populations. Left untreated, it can impair cognitive development, physical performance, pregnancy outcomes, and overall well-being.

Neftaly empowers healthcare workers and community programs to implement effective screening strategies that detect IDA early, guide appropriate intervention, and reduce preventable health burdens.

---

???? Program Objectives

• Understand the causes and risk factors of iron deficiency anemia
• Identify high-risk populations for targeted screening
• Implement practical and cost-effective screening methods
• Link screening results to appropriate nutritional and clinical management
• Promote public health strategies to prevent IDA

---

???? What Is Iron Deficiency Anemia?

Iron Deficiency Anemia occurs when the body lacks enough iron to produce hemoglobin, the protein in red blood cells that carries oxygen. This leads to reduced oxygen delivery to tissues, causing fatigue and other health problems.

---

???? Who Should Be Screened?

Screening is especially important for:

• Infants and young children (especially 6–24 months)
• Adolescent girls
• Pregnant and postpartum women
• Women of reproductive age (due to menstruation and pregnancy demands)
• Individuals with poor diets, chronic infections, or parasitic infestations
• Populations with low socioeconomic status or limited access to iron-rich foods

---

????️ Screening Methods

1. Hemoglobin (Hb) Testing

• Most widely used test
• Low Hb indicates anemia, but not the cause
• Capillary or venous blood sample

2. Serum Ferritin

• Measures iron stores in the body
• Low ferritin confirms iron deficiency (especially <15 ng/mL)
• Elevated in infections/inflammation – interpret with caution

3. Other Supportive Tests

• Mean corpuscular volume (MCV): microcytic cells in IDA
• Transferrin saturation or serum iron (if available)
• C-reactive protein (CRP) to interpret ferritin accurately

---

???? Signs and Symptoms to Look For

• Fatigue and weakness
• Pale skin or conjunctiva
• Dizziness or headaches
• Cold hands and feet
• Pica (craving non-food items)
• Brittle nails or hair loss
• Poor concentration or school performance (in children)

Note: Many individuals with mild IDA may have no symptoms—underscoring the need for routine screening in high-risk groups.

---

???? What Happens After Screening?

If IDA is confirmed:

• Investigate underlying cause (diet, blood loss, parasites, chronic disease)
• Begin iron supplementation (oral or IV, depending on severity and absorption)
• Provide nutrition counseling on iron-rich foods (e.g., meat, legumes, dark leafy greens)
• Address contributing factors (e.g., hookworm, menstrual bleeding, poor diet)
• Monitor response with repeat Hb/ferritin in 4–8 weeks

---

???? Prevention Strategies

• Iron supplementation in pregnancy and early childhood
• Food fortification with iron (e.g., cereals, flour)
• Deworming in endemic areas
• Dietary education promoting iron-rich and vitamin C-rich foods
• Menstrual health support for adolescent girls and women

---

???? Benefits of Early Screening and Treatment

• Improved growth and cognitive development in children
• Healthier pregnancies and birth outcomes
• Enhanced productivity and reduced fatigue in adults
• Decreased need for hospitalizations and advanced care
• Strengthened overall public health outcomes

---

???? Partner With Neftaly

Neftaly provides:

• Screening program design for clinics, schools, and community settings
• Training on anemia identification and management
• Nutrition education materials and public health campaign tools
• Monitoring and evaluation tools to track impact

???? Contact Neftaly to launch or strengthen your Iron Deficiency Anemia screening and prevention efforts today.